Company Announcement no. 7/2015
To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, 4 March, 2015
Notice to Convene Annual General Meeting
The board of directors of Veloxis Pharmaceuticals A/S, CVR no. 26 52 77 67 ("the Company"), hereby convenes the annual general meeting in the Company which will be held on
Thursday 26 March 2015 at 1 pm.
at Søhuset, Venlighedsvej 10, 2970 Hørsholm, Denmark.
Agenda
- Report by the Company's board of directors on the Company’s activities during the past financial year
- Presentation of the audited annual report for approval
- Resolution on covering of losses as per the approved annual report
- Election of members to the board of directors
- Election of auditor
- Proposal by the board of directors on authorization to the board of directors to issue warrants and amendment of the articles of association in accordance therewith
- Proposal by the board of directors for approval of updated remuneration policy including general guidelines for incentive-based remuneration to members of the board of directors and executive management and amendment of the articles of association in accordance therewith
- Approval of fee to the board of directors for the financial year 2015
- Proposal by the board of directors on authorization to the Company to acquire own shares
- Proposal by the board of directors on authorization to the chairman of the annual general meeting
